Frontiers Safety and therapeutic effects of personalized

Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial - The Lancet Gastroenterology & Hepatology

Affinity@Scale: Making an Impact in a Personalized Context

Current Clinical Applications of In Vivo Gene Therapy with AAVs: Molecular Therapy

Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial - The Lancet Oncology

Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer

Drug-microbiota interactions: an emerging priority for precision medicine

Importance of personalized therapies

Polypharmacy and precision medicine, Cambridge Prisms: Precision Medicine

Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial - The Lancet Oncology

FDA Approves Carvykti CAR T-Cell Therapy for Multiple Myeloma - NCI

Wearable and Mobile Sensors for Personalized Nutrition

Prescription Digital Therapeutics a New Frontier in Mental Health Care